Morgan Stanley’s Sensei Biotherapeutics SNSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86 | Sell |
10
-451
| -98% | -$3.88K | ﹤0.01% | 7672 |
|
|
2025
Q1 | $3.63K | Hold |
461
| – | – | ﹤0.01% | 7069 |
|
|
2024
Q4 | $4.52K | Sell |
461
-150
| -25% | -$1.47K | ﹤0.01% | 7029 |
|
|
2024
Q3 | $7.31K | Hold |
611
| – | – | ﹤0.01% | 6806 |
|
|
2024
Q2 | $7.58K | Hold |
611
| – | – | ﹤0.01% | 6754 |
|
|
2024
Q1 | $12.8K | Buy |
611
+589
| +2,677% | +$12.4K | ﹤0.01% | 6608 |
|
|
2023
Q4 | $302 | Buy |
22
+11
| +100% | +$151 | ﹤0.01% | 7320 |
|
|
2023
Q3 | $175 | Hold |
11
| – | – | ﹤0.01% | 7397 |
|
|
2023
Q2 | $250 | Sell |
11
-6,421
| -100% | -$146K | ﹤0.01% | 7436 |
|
|
2023
Q1 | $193K | Buy |
6,432
+6,420
| +53,500% | +$193K | ﹤0.01% | 5722 |
|
|
2022
Q4 | $371 | Sell |
12
-666
| -98% | -$20.6K | ﹤0.01% | 7591 |
|
|
2022
Q3 | $21K | Sell |
678
-631
| -48% | -$19.5K | ﹤0.01% | 6773 |
|
|
2022
Q2 | $59K | Buy |
1,309
+755
| +136% | +$34K | ﹤0.01% | 6542 |
|
|
2022
Q1 | $25K | Sell |
554
-1,288
| -70% | -$58.1K | ﹤0.01% | 7048 |
|
|
2021
Q4 | $214K | Buy |
1,842
+1,676
| +1,010% | +$195K | ﹤0.01% | 6025 |
|
|
2021
Q3 | $35K | Sell |
166
-5,220
| -97% | -$1.1M | ﹤0.01% | 6873 |
|
|
2021
Q2 | $1.05M | Buy |
5,386
+5,057
| +1,537% | +$987K | ﹤0.01% | 5042 |
|
|
2021
Q1 | $96K | Buy |
+329
| New | +$96K | ﹤0.01% | 6042 |
|